{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T21:38:56Z","timestamp":1773437936869,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vaccine.2022.05.032","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T19:16:24Z","timestamp":1653160584000},"page":"3835-3842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial"],"prefix":"10.1016","volume":"40","author":[{"given":"Chun-Mien","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaka M.","family":"Awanye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Marsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Dold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.J.","family":"Maiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-5354","authenticated-orcid":false,"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2022.05.032_b0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1286-4579(00)00356-7","article-title":"Epidemiology and pathogenesis of Neisseria meningitidis","volume":"2","author":"Tzeng","year":"2000","journal-title":"Microb Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8346","key":"10.1016\/j.vaccine.2022.05.032_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.05.032_b0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.032_b0025","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/IAI.66.7.3223-3231.1998","article-title":"Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial","volume":"66","author":"Wedege","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.032_b0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1574-695X.2000.tb01493.x","article-title":"Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine","volume":"28","author":"Milagres","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.032_b0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of infants with meningococcal group B vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.032_b0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3201\/eid1004.030247","article-title":"PorA variable regions of Neisseria meningitidis","volume":"10","author":"Russell","year":"2004","journal-title":"Emerging Infect Dis"},{"issue":"5459","key":"10.1016\/j.vaccine.2022.05.032_b0045","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2022.05.032_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/0-387-25342-4_15","article-title":"Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis","volume":"568","author":"Kelly","year":"2005","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.05.032_b0055","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"issue":"8775","key":"10.1016\/j.vaccine.2022.05.032_b0060","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.032_b0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.032_b0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4161\/hv.7.7.15997","article-title":"Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults","volume":"7","author":"Toneatto","year":"2011","journal-title":"Hum Vaccines"},{"issue":"19","key":"10.1016\/j.vaccine.2022.05.032_b0075","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1128\/JB.00625-13","article-title":"Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis","volume":"195","author":"Lappann","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2022.05.032_b0080","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.032_b0085","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43139-0","article-title":"Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis","volume":"9","author":"Awanye","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.032_b0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jinf.2015.05.006","article-title":"A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial","volume":"71","author":"Marsay","year":"2015","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18791-0","article-title":"Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity","volume":"11","author":"Bartolini","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.05.032_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-61779-346-2_6","article-title":"Expression, purification, and crystallization of neisserial outer membrane proteins","volume":"799","author":"Saleem","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.032_b0110","doi-asserted-by":"crossref","first-page":"e0134353","DOI":"10.1371\/journal.pone.0134353","article-title":"An OMV vaccine derived from a capsular group B meningococcus with constitutive FetA expression: preclinical evaluation of immunogenicity and toxicity","volume":"10","author":"Norheim","year":"2015","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.032_b0115","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/btl117","article-title":"Pvclust: an R package for assessing the uncertainty in hierarchical clustering","volume":"22","author":"Suzuki","year":"2006","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.032_b0120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00273171.2012.734737","article-title":"Default Bayes factors for model selection in regression","volume":"47","author":"Rouder","year":"2012","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.vaccine.2022.05.032_b0125","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"van der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"10.1016\/j.vaccine.2022.05.032_b0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1099\/mic.0.000227","article-title":"Dissection of the function of the RmpM periplasmic protein from Neisseria meningitidis","volume":"162","author":"Maharjan","year":"2016","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.032_b0135","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1073\/pnas.062630899","article-title":"Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis","volume":"99","author":"Prince","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2958.1999.01335.x","article-title":"Projection structure of reconstituted Opc outer membrane protein from Neisseria meningitidis","volume":"32","author":"Collins","year":"1999","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.032_b0145","doi-asserted-by":"crossref","first-page":"e56746","DOI":"10.1371\/journal.pone.0056746","article-title":"Use of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitidis","volume":"8","author":"Saleem","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.032_b0150","doi-asserted-by":"crossref","first-page":"e1002923","DOI":"10.1371\/journal.ppat.1002923","article-title":"Structure and assembly of a trans-periplasmic channel for type IV pili in Neisseria meningitidis","volume":"8","author":"Berry","year":"2012","journal-title":"PLoS Path"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.032_b0155","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tibs.2016.06.005","article-title":"From chaperones to the membrane with a BAM!","volume":"41","author":"Plummer","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"5604","key":"10.1016\/j.vaccine.2022.05.032_b0160","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1078973","article-title":"Role of a highly conserved bacterial protein in outer membrane protein assembly","volume":"299","author":"Voulhoux","year":"2003","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.vaccine.2022.05.032_b0165","doi-asserted-by":"crossref","first-page":"24825","DOI":"10.1074\/jbc.M302803200","article-title":"Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential","volume":"278","author":"Vandeputte-Rutten","year":"2003","journal-title":"J Biol Chem"},{"issue":"481","key":"10.1016\/j.vaccine.2022.05.032_b0170","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1198\/016214507000001337","article-title":"Mixtures of g priors for Bayesian variable selection","volume":"103","author":"Liang","year":"2008","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/hv.34293","article-title":"The discovery and development of a novel vaccine to protect against Neisseria meningitidis serogroup B disease","volume":"11","author":"Zlotnick","year":"2015","journal-title":"Hum Vacc Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.032_b0180","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.05.032_b0185","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2958.2003.03903.x","article-title":"Structure of the OmpA-like domain of RmpM from Neisseria meningitidis","volume":"51","author":"Grizot","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2022.05.032_b0190","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.164.5.1735","article-title":"Immunoglobulin G antibodies directed against Protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum","volume":"164","author":"Rice","year":"1986","journal-title":"J Exp Med"},{"issue":"36","key":"10.1016\/j.vaccine.2022.05.032_b0195","doi-asserted-by":"crossref","first-page":"31489","DOI":"10.1074\/jbc.M506354200","article-title":"Recognition of saccharides by the OpcA, OpaD, and OpaB outer membrane proteins from Neisseria meningitidis","volume":"280","author":"Moore","year":"2005","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.vaccine.2022.05.032_b0200","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1016\/j.vaccine.2010.08.048","article-title":"A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA","volume":"28","author":"Keiser","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.032_b0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2958.1994.tb00416.x","article-title":"Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine","volume":"13","author":"Sarkari","year":"1994","journal-title":"Mol Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.032_b0210","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/JB.185.8.2611-2617.2003","article-title":"Three-dimensional structure of the Neisseria meningitidis secretin PilQ determined from negative stain transmission electron microscopy","volume":"185","author":"Collins","year":"2003","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.032_b0215","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00702-17","article-title":"Multiple structures disclose the secretins' secrets","volume":"200","author":"Filloux","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2022.05.032_b0220","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1099\/mic.0.2007\/015479-0","article-title":"Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB","volume":"154","author":"Bennett","year":"2008","journal-title":"Microbiology-(UK)"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.032_b0225","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/IAI.67.5.2406-2413.1999","article-title":"Structural and evolutionary inference from molecular variation in Neisseria porins","volume":"67","author":"Burns","year":"1999","journal-title":"Infect Immun"},{"issue":"19","key":"10.1016\/j.vaccine.2022.05.032_b0230","doi-asserted-by":"crossref","first-page":"18923","DOI":"10.1074\/jbc.M411603200","article-title":"Interaction with type IV pili induces structural changes in the bacterial outer membrane secretin PilQ","volume":"280","author":"Collins","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.032_b0235","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00674-21","article-title":"Human B cell responses to dominant and subdominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial","volume":"7","author":"Rollier","year":"2022","journal-title":"mSphere"},{"issue":"7592","key":"10.1016\/j.vaccine.2022.05.032_b0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature17199","article-title":"Structural basis of outer membrane protein insertion by the BAM complex","volume":"531","author":"Gu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.05.032_b0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature12521","article-title":"Structural insight into the biogenesis of beta-barrel membrane proteins","volume":"501","author":"Noinaj","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.032_b0250","doi-asserted-by":"crossref","first-page":"e97475","DOI":"10.1371\/journal.pone.0097475","article-title":"Crystal structure of the open state of the Neisseria gonorrhoeae MtrE outer membrane channel","volume":"9","author":"Lei","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.032_b0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jinf.2018.06.001","article-title":"Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies","volume":"77","author":"Wang","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2022.05.032_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008602","article-title":"The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae","volume":"16","author":"Leduc","year":"2020","journal-title":"PLoS Path"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:38Z","timestamp":1759403618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22006168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":52,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0264410X22006168"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}